In English
NIDA

Smoking

NIDA Announces Avant-Garde Medication Development Awards

Dr. Thomas Kosten of Baylor College of Medicine and Dr. Peter Burkhard of the University of Connecticut are the recipients of NIDA’s 2011 Avant-Garde Awards for Innovative Medication Development Research. Dr. Kosten is developing a vaccine against methamphetamine abuse and Dr. Burkhard is developing a vaccine to counter nicotine addiction.

Financial Strain Hinders Smoking Cessation

Helping smokers deal with financial problems could improve their chances of staying abstinent after receiving treatment, according to a new study. Participants with the most financial strain had the least success in remaining abstinent.

Nanotechnology Powers Smart Skin Patch

An in vitro test demonstrates the potential of a programmable skin patch that will enable physicians to tailor transdermal medication doses to match patients' fluctuating needs.

Ethnicity Influences Early Smoking and Progression to Drug Abuse

Summarizes findings from a 10-year study that monitored smoking and progress to other drugs among youth that found ethnicity to be an influential factor.

Nicotine Alters the Developing Rat Brain

Describes animal studies that suggested exposure to the drug during gestation or adolescence may cause lasting alterations in reward and motivation circuits.

Addiction and Co-Occurring Mental Disorders

NIDA Director Nora Volkow

Presents an overview of the research underway to investigate medication and behavioral therapies for co-occurring disorders.

Vaccine May Reduce Fetal Exposure to Nicotine

Describes research on a vaccine developed to facilitate smoking cessation by blocking nicotine penetration into the brain.

Standard Treatments Help Depressed Smokers Quit

Describes a study comparing Staged Care Intervention, a combination treatment for smoking cessation, among smokers in outpatient treatment for depression and a control group.

Naltrexone-Nicotine Patch Combination Shows Promise

Reports findings from a clinical trial investigating the effectiveness of naltrexone as a supplement to nicotine replacement therapy for smoking cessation.

Genes and Smoking

NIDA Director Nora Volkow

Reports on the research underway to identify gene variations associated with nicotine addiction and the interaction of genetic makeup, experiences, and surroundings to addiction.

Páginas

Take the IQ Challenge en Español!